- Home
- NBY vs USBC Comparison
NBY vs USBC Comparison
Compare NBY & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- USBC
- Stock Information
- Founded
- NBY 2000
- USBC N/A
- Country
- NBY United States
- USBC
- Employees
- NBY N/A
- USBC N/A
- Industry
- NBY
- USBC
- Sector
- NBY
- USBC
- Exchange
- NBY Nasdaq
- USBC Nasdaq
- Market Cap
- NBY 15.7M
- USBC 14.5M
- IPO Year
- NBY 2007
- USBC N/A
- Fundamental
- Price
- NBY $2.60
- USBC $0.74
- Analyst Decision
- NBY Strong Buy
- USBC
- Analyst Count
- NBY 1
- USBC 0
- Target Price
- NBY $0.85
- USBC N/A
- AVG Volume (30 Days)
- NBY 21.3M
- USBC N/A
- Earning Date
- NBY 11-06-2025
- USBC N/A
- Dividend Yield
- NBY N/A
- USBC N/A
- EPS Growth
- NBY N/A
- USBC N/A
- EPS
- NBY 0.41
- USBC N/A
- Revenue
- NBY $9,781,000.00
- USBC N/A
- Revenue This Year
- NBY $23.91
- USBC N/A
- Revenue Next Year
- NBY $32.05
- USBC N/A
- P/E Ratio
- NBY $6.50
- USBC N/A
- Revenue Growth
- NBY 113.47
- USBC N/A
- 52 Week Low
- NBY $0.46
- USBC N/A
- 52 Week High
- NBY $4.44
- USBC N/A
- Technical
- Relative Strength Index (RSI)
- NBY 58.86
- USBC N/A
- Support Level
- NBY $2.28
- USBC N/A
- Resistance Level
- NBY $3.12
- USBC N/A
- Average True Range (ATR)
- NBY 0.57
- USBC 0.00
- MACD
- NBY 0.04
- USBC 0.00
- Stochastic Oscillator
- NBY 48.32
- USBC 0.00
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.